Abdulrahim Abu Jayyab
TAs recent studies described Novel Coronavirus Disease
(COVID-19) is commonly complicated with a hypercoagulable
state and increased risk for venous thromboembolism,
deep vein thrombosis (D V T) or fatal pulmonary
thromboembolism (PTE ) Further, COVID-19 has been
found in causing a proinflammatory and hypercoagulable
state with marked increase levels seen in Lactate Dehydrogenase,
Ferritin, C-reactive protein, D-Dimer, and
Interleukin levels. The clinical studies have also demonstrated
severe coronavirus disease 2019 (COVID-19) that
is commonly developed coagulopathy, markedly elevated
D-dimer, which is associated with poor prognosis of severe
COVID-19. This published data indicated that the
Novel Coronavirus Disease (COVID-19) caused a high
incidence of hypercoagulable state among some patients
that caused the sudden death.